Contingencies (Tables)

12 Months Ended

Dec. 31, 2023

Commitments and Contingencies Disclosure [Abstract]

Summary of Insurance Receivable Balances and Activity Related to Product Liability Losses

A summary of insurance receivables balance and activity related to cumulative trauma product liability losses and divestiture of MSA LLC is as follows:

(In millions)	2023		2022
Balance beginning of period	$	127.6	$	130.2
Divestiture of MSA LLC	(127.6)		—
Additions	—		1.8
Collections	—		(4.4)
Balance end of period	$	—	$	127.6

Summary of Notes Receivable from Insurance Companies Activity During the Year

A summary of notes receivables from insurance companies balance is as follows:

	December 31,
(In millions)	2023		2022
Balance beginning of period	$	44.6	$	48.5
Divestiture of MSA LLC	(44.6)		—
Additions	—		1.2
Collections	—		(5.1)
Balance end of period	$	—	$	44.6

Schedule of Product Warranty Liability

The following table reconciles the changes in the Company's accrued warranty reserve:

	December 31,
(In thousands)	2023		2022		2021
Beginning warranty reserve	$	15,230	$	12,423	$	11,428
Warranty payments	(9,794)		(10,631)		(8,987)
Warranty claims	8,899		14,544		10,225
Provision for product warranties and other adjustments	(47)		(1,106)		(243)
Ending warranty reserve	$	14,288	$	15,230	$	12,423

Schedule of Discontinued Operations

Below is a summary of the impact of the divestiture of MSA LLC on our Consolidated Statements of Income for the year ended December 31, 2023:

(In millions)	Year Ended December 31, 2023
Cash and cash equivalents	$	(341.2)
Current insurance receivables	(17.3)
Notes receivable, insurance companies	(5.9)
Noncurrent insurance receivables	(110.3)
Notes receivable, insurance companies, noncurrent	(38.7)
Current product liability	65.1
Noncurrent product liability	324.7
Loss on divestiture of MSA LLC before transaction costs	(123.6)
Transaction costs	(5.6)
Loss on divestiture of MSA LLC	(129.2)
Income tax expense (a)	(70.4)
Tax-effected loss on divestiture of MSA LLC	$	(199.6)
(a) Related to the write-off of deferred tax asset related to product liability reserve